Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Relay Therapeutics, Inc.

NASDAQ: RLAY · Life Sciences · 7 alerts · CIK 1812364

Share price
$17.27Close, Nov 16
Market cap
$3.82B
Shares outstanding
220.96MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Relay Therapeutics, Inc. filings on SEC EDGAR ↗

4:18 PM ET Form 4
Insider Selling

Relay Therapeutics Insider Peter Rahmer Sells $14K of Stock

Peter Rahmer sold 753 shares of Relay Therapeutics, Inc. at $18.62 a share, worth $14K in total on Oct 28, 2026. Shares held after the trade: 222,904 (-0.3%).

Value
$14K
Shares
753
Price
$18.62
Holding change
-0.3%
Trade date
Oct 28, 2026
4:16 PM ET Form 4
Insider Selling

Relay Therapeutics President, R&D Donald A. Bergstrom Sells $41.9K of Stock

Donald A. Bergstrom, President, R&D, sold 2,252 shares of Relay Therapeutics, Inc. at $18.62 a share, worth $41.9K in total on Oct 28, 2026. Shares held after the trade: 396,878 (-0.6%).

Value
$41.9K
Shares
2,252
Price
$18.62
Role
President, R&D
Holding change
-0.6%
Trade date
Oct 28, 2026
4:15 PM ET Form 4
Insider Selling

Relay Therapeutics CFO Thomas Catinazzo Sells $27.4K of Stock

Thomas Catinazzo, CFO, sold 1,469 shares of Relay Therapeutics, Inc. at $18.62 a share, worth $27.4K in total on Oct 28, 2026. Shares held after the trade: 103,665 (-1.4%).

Value
$27.4K
Shares
1,469
Price
$18.62
Role
CFO
Holding change
-1.4%
Trade date
Oct 28, 2026
5:29 PM ET Form 4
Insider Selling

Relay Therapeutics President and CEO Sanjiv Patel Sells $872K of Stock

Sanjiv Patel, President and CEO, sold 48,199 shares of Relay Therapeutics, Inc. at $18.10 a share, worth $872K in total on Oct 7, 2026. Shares held after the trade: 471,301 (-9.3%).

Value
$872K
Shares
48,199
Price
$18.10
Role
President and CEO
Holding change
-9.3%
Trade date
Oct 7, 2026
5:29 PM ET Form 4
Insider Selling

Relay Therapeutics CFO Thomas Catinazzo Sells $325K of Stock

Thomas Catinazzo, CFO, sold 17,511 shares of Relay Therapeutics, Inc. at $18.58 a share, worth $325K in total on Oct 6, 2026. Shares held after the trade: 105,340 (-14.3%).

Value
$325K
Shares
17,511
Price
$18.58
Role
CFO
Holding change
-14.3%
Trade date
Oct 6, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.